CellSource Co., Ltd. (TYO:4880)
271.00
-1.00 (-0.37%)
Nov 18, 2026, 10:38 AM JST
CellSource Market Cap
CellSource has a market cap or net worth of 5.38 billion as of November 17, 2026. It is the 32,729th most valuable company in the world and the 2,970th biggest in Japan. Its market cap has decreased by 45.39% in one year.
Market Cap
5.38B
Enterprise Value
593.57M
Revenue
3.67B
Global Rank
Country Rank
#2,970 Japan
PE Ratio
76.75
ChartMarket Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 5.38B, a decrease of -60.09%. That is a compound annual growth rate of -12.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 5.38B | -31.98% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 6.56B |
| OncoTherapy Science | 6.53B |
| J-Pharma | 6.45B |
| TMS Co., Ltd. | 6.12B |
| Nano Holdings | 6.10B |
| Chiome Bioscience | 6.08B |
| Soiken Holdings | 5.52B |
| BrightPath Biotherapeutics | 5.28B |